ProQR Therapeutics N.V.

ProQR Therapeutics N.V. - PE Ratioverified

PRQR

Price:

$1.89

Market Cap:

$173.54M

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ultevursen is also undergoing Phase II/III evaluation for the treatment of USH2A-mediated retinitis pigmentosa and Usher syndrome. Beyond its clinical programs, ProQR is actively developing its proprietary Axiomer RNA base-editing platform technology. Strategic collaborations are central to ProQR's strateg...[Read more]

Industry

Biotechnology

IPO Date

2014-09-18

Stock Exchange

NASDAQ

Ticker

PRQR

The PE Ratio as of June 2026 (TTM) for ProQR Therapeutics N.V. (PRQR) is -3.78

According to ProQR Therapeutics N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -3.78. This represents a change of -4.84% compared to the average of -3.97 of the last 4 quarters.

ProQR Therapeutics N.V. (PRQR) Historical PE Ratio (quarterly & annually)

How has PRQR PE Ratio performed in the past?

The mean historical PE Ratio of ProQR Therapeutics N.V. over the last ten years is -5.55. The current -3.78 PE Ratio has changed 6.71% with respect to the historical average. Over the past ten years (40 quarters), PRQR's PE Ratio was at its highest in in the September 2022 quarter at -0.56. The PE Ratio was at its lowest in in the September 2018 quarter at -24.25.

Quarterly (TTM)
Annual

Average

-5.55

Median

-4.82

Minimum

-12.74

Maximum

-1.60

ProQR Therapeutics N.V. (PRQR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ProQR Therapeutics N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 697.20%

Maximum Annual PE Ratio = -1.60

Minimum Annual Increase = -68.97%

Minimum Annual PE Ratio = -12.74

Quarterly (TTM)
Annual
YearPE RatioChange
2025-4.52-39.89%
2024-7.5347.06%
2023-5.1234.78%
2022-3.80-48.25%
2021-7.3498.57%
2020-3.70-42.30%
2019-6.40-49.74%
2018-12.74697.20%
2017-1.60-42.64%
2016-2.79-68.97%

ProQR Therapeutics N.V. (PRQR) Average PE Ratio

How has PRQR PE Ratio performed in the past?

The current PE Ratio of ProQR Therapeutics N.V. (PRQR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.72

5-year avg

-5.66

10-year avg

-5.55

ProQR Therapeutics N.V. (PRQR) PE Ratio vs. Peers

How is PRQR’s PE Ratio compared to its peers?

ProQR Therapeutics N.V.’s PE Ratio is less than Immutep Limited (-0.92), less than Editas Medicine, Inc. (-2.19), greater than Capricor Therapeutics, Inc. (-12.23), greater than Achieve Life Sciences, Inc. (-4.33), less than Allogene Therapeutics, Inc. (-2.60), less than Arcturus Therapeutics Holdings Inc. (-2.66), less than Mereo BioPharma Group plc (-1.38), less than Vanda Pharmaceuticals Inc. (-1.43), less than Entrada Therapeutics, Inc. (-1.77), less than Zura Bio Limited (-3.44),

Build a custom stock screener for ProQR Therapeutics N.V. (PRQR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProQR Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProQR Therapeutics N.V. (PRQR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProQR Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ProQR Therapeutics N.V.'s PE Ratio?

How is the PE Ratio calculated for ProQR Therapeutics N.V. (PRQR)?

What is the highest PE Ratio for ProQR Therapeutics N.V. (PRQR)?

What is the 3-year average PE Ratio for ProQR Therapeutics N.V. (PRQR)?

What is the 5-year average PE Ratio for ProQR Therapeutics N.V. (PRQR)?

How does the current PE Ratio for ProQR Therapeutics N.V. (PRQR) compare to its historical average?